Company Profiles

driven by the PitchBook Platform

Principia Biopharma

Description

Developer of cancer drugs designed to offer clinical and preclinical stage molecules for autoimmune, inflammatory diseases and oncology. The company's cancer drugs are developed by combine the dosing convenience of an oral small molecule drug with the specificity of an antibody, enabling patients to get new medicine with long lasting efficacy.

2008

Founded

PRIVATE

Status

51-200

Employees

Series B3

Latest Deal Type

$15.3M

Latest Deal Amount

$102M

Total Amount Raised

Description

Developer of cancer drugs designed to offer clinical and preclinical stage molecules for autoimmune, inflammatory diseases and oncology. The company's cancer drugs are developed by combine the dosing convenience of an oral small molecule drug with the specificity of an antibody, enabling patients to get new medicine with long lasting efficacy.

Website:

www.principiabio.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Biotechnology

Primary Office

400 East Jamie Court Suite 302 South San Francisco, CA 94080United States +1 (650) 416-7700
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Principia Biopharma's full profile, request a free trial.

    Principia Biopharma Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Principia Biopharma Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Principia Biopharma Investors (6)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Mission Bay CapitalVenture CapitalMinority000 0000000 0000
    Morgenthaler VenturesVenture CapitalMinority000 0000000 0000
    New Leaf Venture PartnersVenture CapitalMinority000 0000000 0000
    OrbiMedVenture CapitalMinority000 0000000 0000
    Sofinnova VenturesVenture CapitalMinority000 0000000 0000
    Mission Bay Capital Venture Capital
    Morgenthaler Ventures Venture Capital
    New Leaf Venture Partners Venture Capital
    OrbiMed Venture Capital
    Sofinnova Ventures Venture Capital

    Principia Biopharma Executive Team (8)

    NameTitleBoard
    Seat
    Contact
    Info
    Martin BablerChief Executive Officer, President & Board Member
    Christopher ChaiChief Financial Officer
    David Goldstein Ph.DChief Scientific Officer
    Roy Hardiman JDChief Business Officer
    Betsy SantosHead, Human Resources
    Martin Babler Chief Executive Officer, President & Board Member
    Christopher Chai Chief Financial Officer
    David Goldstein Ph.D Chief Scientific Officer
    Roy Hardiman JD Chief Business Officer
    Betsy Santos Head, Human Resources

    Principia Biopharma Board Members (10)

    NameRepresentingRoleSinceContact
    Info
    Dan Becker Ph.DNew Leaf Venture PartnersPrincipal000 0000
    David Kabakoff Ph.DSofinnova VenturesExecutive Partner, Private Equity000 0000
    Jack Taunton Ph.DSelfBoard Observer000 0000
    Lewis ShusterSelfDirector000 0000
    Martin BablerPrincipia BiopharmaChief Executive Officer, President & Board Member000 0000
    Dan Becker Ph.D Principal New Leaf Venture Partners
    David Kabakoff Ph.D Executive Partner, Private Equity Sofinnova Ventures
    Jack Taunton Ph.D Board Observer Self
    Lewis Shuster Director Self
    Martin Babler Chief Executive Officer, President & Board Member Principia Biopharma
    Request full access to PitchBook